Fonte: Fortune
The FDA has cleared Merck’s Lipfendra for patients whose artery‑clogging cholesterol remains high despite statins.
Ler na Fonte
Notícias Relacionadas
Lista de Notícias
Fonte: Fortune
The FDA has cleared Merck’s Lipfendra for patients whose artery‑clogging cholesterol remains high despite statins.